Clinicians & therapists
For doctors, nurses, therapists and psychologists.
- Neuropsychology22 Apr
A study on a nature-based programme of activities for patients with mild to moderate mental health conditions has shown that participants saw improvements in mood and anxiety levels in as little as 12 weeks. As part of the UK government’s commitment to transform mental health services, seven ‘test and learn’ green social prescribing sites were [...]
- Neuropsychology16 Apr
Patients with depression who received the Moodivate app saw clinically meaningful reductions in their symptoms that were twice those achieved with standard-of-care therapy in a clinical trial conducted at 22 primary care practices. The study found that app users were also three times more likely to achieve a clinically meaningful improvement in their depression and [...]
- Neuropsychology31 Mar
The Lieber Institute for Brain Development has announced the progression toward clinical testing of a unique, centrally acting catechol Omethyltransferase (COMT) inhibitor from its collaboration with Boehringer Ingelheim. COMT is a dopamine-metabolising enzyme involved in the regulation of neurotransmitter levels. These are critical for cognitive and behavioural processes that are impaired in several neuropsychiatric disorders. While [...]
- Therapy25 Mar
A Phase 3 trial of intrathecal onasemnogene abeparvovec (OAV101 IT) - an investigational gene replacement therapy - in children ages two to 18 years with spinal muscular atrophy (SMA) has shown positive results. OAV101 IT is designed to directly address the genetic root cause of the disease by replacing the nonworking SMN1 gene with a [...]
- Neuropsychology24 Mar
Almost half of patients diagnosed with depression classify as being ‘treatment-resistant’, as new research suggests that many don’t respond to multiple antidepressant options. The study found that 48 per cent of patients whose electronic healthcare records reported a diagnosis of depression had tried at least two antidepressants, and 37 per cent had tried four or [...]
- Neuropsychology21 Mar
Neuroscientists have discovered a way to control how much zinc is released to specific locations in the brain. The essential mineral plays a major role in the organ’s function, including improving memory and lessening symptoms of some neurological disorders, but getting the right amount to the right place is key. The study focuses on the [...]
- Therapy21 Mar
A new study investigating how a parakeet’s brain helps it to mimic human words has established the bird as an important animal model for investigating speech motor control, and researchers say the findings could help develop therapeutic solutions for addressing a range of communication disorders. By recording for the first time the brain activity of [...]
- Neuropsychology5 Mar
A final year medical student, who starts as a resident doctor in August, has praised a consultant psychiatrist and mentor who has “filled me with confidence and inspiration”. Jing Wang, who has been studying Medicine at the University of Cambridge, spent a period of time shadowing Dr Alexander Hamilton, who works at mental health charity [...]
- Neuropsychology5 Mar
By Charlotte Naylor, Research Assistant, Sarah Lake, Research Assistant, Dr Penny Trayner, Co-Founder and Consultant Clinical Neuropsychologist and Mark Blundell, Co-Founder, BPM Rehab Anxiety can significantly impair an individual's quality of life, hindering their social functioning and emotional well-being. When left unaddressed, anxiety has the potential to evolve into more chronic mental health conditions, exacerbating [...]
- Therapy5 Mar
Fourier Rehab is set to host GReAT 2025, a premier global summit bringing together experts, innovators, and thought leaders in rehabilitation technology. Taking place at the Fourier Shanghai Headquarters from April 23-24, 2025, this exclusive event will provide insights into the latest advancements in assistive technology and rehabilitation solutions. Since its inception in 2020, the [...]













